Time to check your inboxes! Just last week, we released Part 1 of our 2022 payer landscape report, Perspectives on Vertical Payers. It summarizes key drivers that lead the biggest payers to "go vertical,” describes vertical payer structures and the role of their healthcare services, and identifies their likely impact on manufacturers’ business landscape.
This report reflects our commitment to help our valued clients…
Payers are verticalizing to keep more revenues ‘in-house’ - our slide below features more insight on exactly why that is and how that affects the delivery of care:
Don’t hesitate to check out this report in our client portal and stay tuned next week for the release of Part 2, Vertical Payer Profiles, which delivers a deep dive into specifics about each of our country’s 6 largest vertical payers.
As always, please reach out with any comments or questions you have.
All the best...
-- HMP Market Access Insights Team
In the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.
Lee BlansettBispecific antibodies have emerged with great promise, but adoption has been slower than expected. This was a key topic discussed by a panel of 5 experts at the October 2024 Association for Value-Based Cancer Care (AVBCC) conference.
Chris Van DenburgIn part 2 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the operational realities of oncology practice economics.
Lee Blansett